8 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | $90M | -$54M | 74.2% | -59.3% | -$33M | $37M | $70M |
| 2024 | $84M | -$56M | 74.0% | -68.9% | -$33M | $40M | $71M |
| 2023 | $69M | -$61M | 73.9% | -90.2% | -$38M | $39M | $84M |
| 2022 | $54M | -$59M | 74.3% | -109.3% | -$46M | $17M | $102M |
| 2021 | $48M | -$49M | 73.6% | -97.7% | -$45M | $18M | $148M |
| 2020 | $33M | -$32M | 64.8% | -98.8% | -$32M | $17M | $232M |
| 2019 | $33M | -$21M | 68.8% | -54.7% | -$21M | — | $15M |
| 2018 | $20M | -$18M | 61.4% | -75.2% | -$19M | — | $4M |
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Mar '26 | $21M | -$14M | 77.9% | -62.9% | -$10M | $37M | $62M |
| Dec '25 | $23M | -$10M | 77.6% | -43.8% | -$7M | $37M | $70M |
| Sep '25 | $22M | -$14M | 74.7% | -66.9% | -$8M | $37M | $77M |
| Jun '25 | $24M | -$15M | 72.1% | -62.0% | -$4M | $37M | $75M |
| Mar '25 | $23M | -$14M | 72.5% | -64.6% | -$14M | $45M | $75M |
| Dec '24 | $24M | -$13M | 74.0% | -56.5% | -$7M | $40M | $71M |
| Sep '24 | $20M | -$14M | 73.7% | -69.3% | -$8M | $37M | $63M |
| Jun '24 | $21M | -$15M | 73.7% | -75.2% | -$6M | $37M | $63M |
| Mar '24 | $19M | -$14M | 74.7% | -77.1% | -$12M | $42M | $70M |
| Dec '23 | $19M | -$14M | 74.7% | -72.2% | -$9M | $39M | $84M |
| Sep '23 | $18M | -$15M | 73.7% | -85.9% | -$9M | $37M | $95M |
| Jun '23 | $17M | -$16M | 74.1% | -95.6% | -$8M | $37M | $102M |
| Mar '23 | $15M | -$16M | 72.9% | -112.8% | -$13M | $37M | $110M |
| Dec '22 | $15M | -$14M | 72.5% | -94.8% | -$10M | $17M | $102M |
| Sep '22 | $14M | -$14M | 75.2% | -103.2% | -$11M | $22M | $112M |
| Jun '22 | $14M | -$15M | 74.7% | -103.3% | -$10M | $20M | $122M |
| Mar '22 | $11M | -$16M | 75.2% | -145.3% | -$16M | $18M | $129M |
| Dec '21 | $14M | -$13M | 74.8% | -90.2% | -$12M | $18M | $148M |
| Sep '21 | $13M | -$10M | 73.4% | -73.6% | -$10M | $17M | $188M |
| Jun '21 | $12M | -$13M | 74.0% | -103.9% | -$13M | $17M | $199M |
How the market has priced LUNG against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 5 years, Pulmonx Corp's revenue has grown 22.6% per year. These are computed facts, not advice.
As of FY2025, Pulmonx Corp reported $37M of total debt against $70M of cash; operating income covered interest expense -17.0×.
In FY2025, gross margin was 74.2%, operating margin -59.3%, and net margin -59.7%.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.